Jakob Dupont - Sep 3, 2024 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Director
Signature
/s/ Jakob Dupont
Stock symbol
BOLT
Transactions as of
Sep 3, 2024
Transactions value $
$0
Form type
4
Date filed
9/6/2024, 12:19 PM
Previous filing
Mar 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +50K $0.00 50K Sep 3, 2024 Common Stock 50K $0.68 Direct F1
transaction BOLT Stock Option (Right to Buy) Award $0 +17K $0.00 17K Sep 3, 2024 Common Stock 17K $0.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following September 3, 2024; provided, however that the option will vest in full upon a change in control.
F2 The shares subject to this option shall vest in full on the date immediately preceding the date of the Issuer's next annual stockholder meeting for so long as the Reporting Person is serving as a director of the Issuer on such date; provided, however that the option will vest in full upon a change in control.